These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2172394)

  • 1. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants.
    Bernstein DI; Smith VE; Sander DS; Pax KA; Schiff GM; Ward RL
    J Infect Dis; 1990 Nov; 162(5):1055-62. PubMed ID: 2172394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season.
    Clark HF; Borian FE; Bell LM; Modesto K; Gouvea V; Plotkin SA
    J Infect Dis; 1988 Sep; 158(3):570-87. PubMed ID: 2842405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3.
    Clark HF; Borian FE; Plotkin SA
    J Infect Dis; 1990 Jun; 161(6):1099-104. PubMed ID: 2161038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local and systemic antibody response to rotavirus WC3 vaccine in adult volunteers.
    Bernstein DI; Kacica MA; McNeal MM; Schiff GM; Ward RL
    Antiviral Res; 1989 Dec; 12(5-6):293-300. PubMed ID: 2561335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection.
    Ward RL; Sander DS; Schiff GM; Bernstein DI
    J Infect Dis; 1990 Dec; 162(6):1298-303. PubMed ID: 2172404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.
    Clark HF; Bernstein DI; Dennehy PH; Offit P; Pichichero M; Treanor J; Ward RL; Krah DL; Shaw A; Dallas MJ; Laura D; Eiden JJ; Ivanoff N; Kaplan KM; Heaton P
    J Pediatr; 2004 Feb; 144(2):184-90. PubMed ID: 14760258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants.
    Treanor JJ; Clark HF; Pichichero M; Christy C; Gouvea V; Shrager D; Palazzo S; Offit P
    Pediatr Infect Dis J; 1995 Apr; 14(4):301-7. PubMed ID: 7603812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.
    Block SL; Vesikari T; Goveia MG; Rivers SB; Adeyi BA; Dallas MJ; Bauder J; Boslego JW; Heaton PM;
    Pediatrics; 2007 Jan; 119(1):11-8. PubMed ID: 17200266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
    Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
    Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response of infants and children to low-passage bovine rotavirus (strain WC3).
    Clark HF; Furukawa T; Bell LM; Offit PA; Perrella PA; Plotkin SA
    Am J Dis Child; 1986 Apr; 140(4):350-6. PubMed ID: 3006476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trial of rhesus rotavirus vaccine in infants.
    Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
    Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
    JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
    Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
    Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
    Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype 1 rotavirus.
    Ukae S; Nakata S; Adachi N; Kogawa K; Chiba S
    Vaccine; 1994 Aug; 12(10):933-9. PubMed ID: 7975835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants.
    Clements-Mann ML; Dudas R; Hoshino Y; Nehring P; Sperber E; Wagner M; Stephens I; Karron R; Deforest A; Kapikian AZ
    Vaccine; 2001 Sep; 19(32):4676-84. PubMed ID: 11535316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants.
    Midthun K; Halsey NA; Jett-Goheen M; Clements ML; Steinhoff M; King JC; Karron R; Wilson M; Burns B; Perkis V
    J Infect Dis; 1991 Oct; 164(4):792-6. PubMed ID: 1654365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of rotavirus vaccine trials in Finland.
    Vesikari T; Joensuu J
    J Infect Dis; 1996 Sep; 174 Suppl 1():S81-7. PubMed ID: 8752295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
    Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
    Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Wasserman SS; Glass RI; Keane VA
    Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.